Abstract:After the discovery of erythromycin and other natural compounds, including oleandomycin, spiramycin, josamycin and midecamycin, much research has been devoted to synthesizing derivatives or analogues with improved chemical, biological and pharmacokinetic properties. These new macrolides are semisynthetic molecules that differ from the original compounds in their substitution pattern of the lactone ring system. The chemical structure of macrolides is characterized by a large lactone ring containing from 12 to 16 atoms to which are attached, via glycosidic bonds, one or more sugars. The lactone ring is substituted by hydroxyl or alkyl groups, one ketone at C7 in 12-membered macrolides and at C9 in 14-membered macrolides, and one aldehyde group in 16-membered macrolides. The only compound with a 15-membered ring contains a tertiary amino group. Although the 12-membered macrolides have never become important in clinical practice, in recent years numerous new 14-membered macrolide derivatives of erythromycin A have shown improved pharmacokinetics due to chemical modifications of a hydroxyl group at C6, a proton at C8, or a ketone at C9. Derivatives, such as dirithromycin, roxithromycin, clarithromycin and flurithromycin, have all been synthesized with the aim of inhibiting their decomposition under acidic conditions to inactive anhydrohemiketal derivatives. A new 15-membered macrolide, azithromycin, with a methylated nitrogen inserted into the lactone ring shows good activity against Gram-negative bacteria. The efforts expended in chemical and biochemical modifications of 16-membered macrolides have been less successful, with only a few new molecules, such as rokitamycin and miocamycin, showing improved bioavailability and activity against some resistant micro-organisms.(ABSTRACT TRUNCATED AT 250 WORDS)

Recent Progress in Studies on New Generation Erythromycin Derivatives and Their Structure-activity Relationship

Various Novel Erythromycin Derivatives Obtained by Different Modifications: Recent Advance in Macrolide Antibiotics

Recent Progress in Research on 4″-O-Substituted Erythromycin Derivatives

Cyclization Strategies in Modification of Erythromycin Derivatives

The research advancement and synthesis of ketolides

Recent Advances in the Development of Macrolide Antibiotics As Antimicrobial Agents

Synthesis and Antibacterial Activity of Novel 10,11-Epoxy Acylide Erythromycin Derivatives

Significant Breakthroughs in Search for Anti-Infectious Agents Derived from Erythromycin A

Structure-Activity Relationships and Mechanism of Action of Macrolides Derived from Erythromycin as Antibacterial Agents

Recent advances in the field of 16-membered macrolide antibiotics.

Synthesis and Structure-Activity Relationships of Novel 14-Membered 2-Fluoro Ketolides with Structural Modification at the C11 Position.

From Erythromycin to Azithromycin and New Potential Ribosome-Binding Antimicrobials

The Advances of the Research on Macrolide Antibiotics

Scaffold Modifications in Erythromycin Macrolide Antibiotics. A Chemical Minireview

Synthesis of Novel 15-Membered Macrolide Derivatives

Synthesis and antibacterial activity of novel 11-[3-[(arylcarbamoyl)oxy]propylamino]-11-deoxy-6-O-methyl-3-oxoerythromycin A 11-N,12-O-cyclic carbamate derivatives

Chemistry and mode of action of macrolides

Synthesis and antibacterial activity of 3-O-carbamoyl derivatives of 6,11-di-O-methylerythromycin A: a novel class of acylides.

Design, Synthesis and Structure-activity Relationships of Novel Non-ketolides: 9-Oxime Clarithromycin Featured with Seven- to Thirteen-atom-length Diamine Linkers at 3-OH

Synthesis and Antibacterial Evaluation of a Novel Series of 10-Hydroxyl Ketolide Derivatives.

Synthesis and Antibacterial Activity of 4″,11-Di-o-arylalkylcarbamoyl Azithromycin Derivatives